Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LIMN · as of Jun 9, 2026
Key Statistics
Explore Liminatus Pharma, Inc. Class A Common Stock Data
limn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
limn competitorsLIMN
ATHE
BTAI
DYAI
EVAX
GBIOStock Performance
Full HistoryAbout Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, C…
what is liminatus pharma, inc. class a common stock · limn stock overview · liminatus pharma, inc. class a common stock company profile · who is liminatus pharma, inc. class a common stock ceo · limn NASDAQ · liminatus pharma, inc. class a common stock headquarters · liminatus pharma, inc. class a common stock business segments
About Stock Overview & Key Data
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 1, 2025. As of the latest trading session, LIMN stock price is $0.14, with a market capitalization of $3.8M. The stock has returned -99.46% over the past 12 months and -76.89% year-to-date.
In fiscal year 2025, Liminatus Pharma, Inc. Class A Common Stock reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock price is $0.14. The stock is traded on NASDAQ under the ticker symbol LIMN. The 52-week range is $0.13 – $33.66.